EcoDrugPlus

Adenosine A2a Receptor

Ensembl ID : ENSPPRG00000003238
Gene Symbol: ADORA2A
4 Cross references
260 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSPPRG00000004239
Gene Symbol: ADORA2B
4 Cross references
200 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSPPRG00000001196
Gene Symbol: ADORA3
4 Cross references
89 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSPPRG00000013211
Gene Symbol: ADA
4 Cross references
216 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSPPRG00000000941
Gene Symbol: ADRA1A
4 Cross references
201 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSPPRG00000014950
Gene Symbol: ADRA1B
4 Cross references
263 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSPPRG00000011828
Gene Symbol: ADRA1D
4 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSPPRG00000016121
Gene Symbol: ADRA2A
4 Cross references
230 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSPPRG00000020232
Gene Symbol: ADRA2B
4 Cross references
219 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSPPRG00000023307
Gene Symbol: ADRA2C
3 Cross references
227 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSPPRG00000015122
Gene Symbol: ADRB1
4 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSPPRG00000003693
Gene Symbol: ADRB2
2 Cross references
262 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).